<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>48(11)</volume><submitter>McCabe C</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>To evaluate the effectiveness and safety of the DFT015 intraocular lens (IOL) (AcrySof IQ Vivity Extended Vision) compared with an aspheric monofocal control IOL (AcrySof IQ model SN60WF).&lt;h4>Setting&lt;/h4>11 investigation sites in the U.S.&lt;h4>Design&lt;/h4>Prospective randomized controlled clinical study.&lt;h4>Methods&lt;/h4>Patients aged 22 years or older with bilateral cataracts were randomized to receive bilateral implantation of DFT015 or SN60WF. The 4 coprimary effectiveness outcomes (6 months postoperatively) were monocular photopic distance-corrected intermediate visual acuity (DCIVA), monocular photopic corrected distance visual acuity (CDVA), monocular depth of focus (DoF), and the percentage of patients achieving a DCIVA of 0.2 logMAR or better. The mean monocular photopic</pubmed_abstract><journal>Journal of cataract and refractive surgery</journal><pagination>1297-1304</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9622364</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design.</pubmed_title><pmcid>PMC9622364</pmcid><pubmed_authors>Newsom TH</pubmed_authors><pubmed_authors>Berdahl J</pubmed_authors><pubmed_authors>Reiser H</pubmed_authors><pubmed_authors>Lemp-Hull J</pubmed_authors><pubmed_authors>McCabe C</pubmed_authors><pubmed_authors>Jasti S</pubmed_authors><pubmed_authors>Koch D</pubmed_authors><pubmed_authors>Cibik L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design.</name><description>&lt;h4>Purpose&lt;/h4>To evaluate the effectiveness and safety of the DFT015 intraocular lens (IOL) (AcrySof IQ Vivity Extended Vision) compared with an aspheric monofocal control IOL (AcrySof IQ model SN60WF).&lt;h4>Setting&lt;/h4>11 investigation sites in the U.S.&lt;h4>Design&lt;/h4>Prospective randomized controlled clinical study.&lt;h4>Methods&lt;/h4>Patients aged 22 years or older with bilateral cataracts were randomized to receive bilateral implantation of DFT015 or SN60WF. The 4 coprimary effectiveness outcomes (6 months postoperatively) were monocular photopic distance-corrected intermediate visual acuity (DCIVA), monocular photopic corrected distance visual acuity (CDVA), monocular depth of focus (DoF), and the percentage of patients achieving a DCIVA of 0.2 logMAR or better. The mean monocular photopic</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-05-18T11:34:07.166Z</modification><creation>2024-10-18T02:34:45.406Z</creation></dates><accession>S-EPMC9622364</accession><cross_references><pubmed>35616507</pubmed><doi>10.1097/j.jcrs.0000000000000978</doi></cross_references></HashMap>